Drug intelligence / Profile preview

Zhengchangsheng

Development stage: Unknown
Lead developer: 东北制药集团沈阳第一制药有限公司
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Zhengchangsheng is a live biotherapeutic product containing *Bacillus licheniformis* live bacteria. It is primarily used for the treatment of acute and chronic enteritis and diarrhea caused by bacterial or fungal infections, as well as for the prevention and treatment of intestinal flora imbalance. Its mechanism of action involves antagonizing pathogenic bacteria, promoting the growth of beneficial bacteria, producing antibacterial substances, and creating an anaerobic environment in the gut to restore microbial balance.

Brand names: Zhengchangsheng
Other names: 整肠生Bacillus Licheniformis Granules, LiveBacillus Licheniformis Capsule, Live地衣芽孢杆菌活菌颗粒地衣芽孢杆菌活菌胶囊

Beyond the preview

Go deeper on Zhengchangsheng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhengchangsheng.

Explore the full profile